Titlebook: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology; Scientific and Clini M. R. Nowrousian Book 20021st edition Springer-Verlag/W

向前变椭圆

rhEPO in pediatric oncology, growth factors have been used to reduce the degree and duration of chemotherapy-induced myelosuppression, the main adverse effect of chemotherapy (Furman 1992; Trillet-Lenoir et al. 1993; Burdach et al. 1995; Riikonen et al. 1995; Mitchell et al. 1997; Rahiala et al. 1999).

我要威胁

怕失去钱

CRUDE

Clinical trials using rhEPO in radiation oncology,of which may be an impaired oxygen-dependent radiosensitivity (Becker et al. 2000; Henke et al. 2000b) — the oxygen-effect (Gray et al. 1953). Thus, it is hoped that the correction of the anemic state of these patients can improve tumor oxygenation and, eventually, cancer cure.

TOM

by world experts in the fieldAnemia is a frequent complication of cancer and its treatment. A number of clinical studies shows that the impact of anemia is much greater than previously thought. Beyond clinical symptoms, anemia significantly impairs physical and metabolic functions as well as patien

神经

Contort

abduction

赏钱

冥界三河